Document:

Confidential Settlement Agreement And Mutual General Release

 Exhibit 10.2 
 CONFIDENTIAL SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE 
 This Confidential Settlement
Agreement and Mutual General Release (“Agreement”), dated this 31st day of May, 2007, is made and entered into by and between PLAINTIFF/COUNTER-DEFENDANT ALLENDALE PHARMACEUTICALS, INC. (“Allendale”), THIRD-PARTY DEFENDANT
TODAY’S WOMENCARE COMPANY, and DEFENDANT/COUNTER-CLAIMANT RADIANT TECHNOLOGIES, INC. (“Radiant”). 
 I. DEFINITIONS

 The following terms as used in this Agreement shall be defined as set forth below: 
 1. All references to “Allendale” shall refer to Plaintiff/Counter-Defendant Allendale Pharmaceuticals, Inc., its predecessors, successors,
parents, subsidiaries, affiliated entities, assigns, divisions, directors, officers, shareholders, agents, employees, attorneys and representatives including, but not limited to, Today’s WomenCare Company and Synova Healthcare Group, Inc.
(“Synova”). 
 2. All references to “Radiant” shall refer to Defendant/Counter-Claimant Radiant Technologies, Inc., its
predecessors, successors, parents, subsidiaries, affiliated entities, assigns, divisions, directors, officers, shareholders, agents, employees, attorneys and representatives including, but not limited to, Pathfinder Management, Inc. 
 3. All references to “Party” or “Parties” shall refer to “Allendale” and “Radiant” as defined above. 

 

 Page 1 

 4. All references to the “Lawsuit” shall refer to the matter captioned Allendale
Pharmaceuticals, Inc. v. Radiant Technologies, Inc., et al., bearing Docket No. 06 CV 3465, filed in the United States District Court for the Southern District of New York. 
 II. RECITALS 
 WHEREAS Allendale and Radiant entered into an
agreement dated March 9, 2004 entitled, “Exclusive Distribution and Services Agreement” (the “Distribution Agreement”); and 
 WHEREAS Allendale and Radiant entered into an agreement dated March 9, 2004 entitled, “Loan and Credit Agreement” (the “Loan and Credit Agreement”); and 
 WHEREAS Allendale and Radiant entered into an agreement dated March 9, 2004 entitled, “Common Stock Purchase Agreement”
(“Stock Purchase Agreement”); and 
 WHEREAS Allendale filed the Lawsuit against Radiant on May 5, 2006 asserting a
breach of contract claim (Count I), a breach of the Covenant of Good Faith and Fair Dealing claim (Count II), and a claim for Declaratory Judgment (Count III); and 
 WHEREAS Radiant filed an Answer, Counterclaim, and Third-Party Complaint to the Lawsuit on July 24, 2006 asserting in its Counterclaim a breach of contract claim (Count I), a claim for Declaratory Judgment
(Count II), and a claim for breach of the Loan and Credit Agreement (Count III); and 
 WHEREAS Allendale filed an Answer to
Radiant’s Counterclaim and Third-Party Complaint on August 14, 2006; and 
 WHEREAS on January 12, 2007, Synova
acquired Allendale by merger; and 
 WHEREAS the Parties have agreed to amicably resolve all their differences arising from and
related to the Lawsuit. 
  

 Page 2 

 NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged by the Parties, and in consideration of the foregoing recitals and of the mutual covenants and agreements contained herein, and intending to be legally bound, the Parties do hereby covenant and agree as follows: 
 III. AGREEMENT TERMS 
  

	A.	Payment of Settlement Amount, Transfer of Stock and Assignment/Conveyance of Accounts Receivable 

 1. Subject to the other conditions and limitations contained herein, Synova, on behalf of Allendale, shall cause to be transferred to Radiant one million
(1,000,000) shares of Synova common stock, which transfer of stock shall occur within ten (10) business days of the execution of this Agreement. The parties acknowledge that Radiant’s has the right to receive 145,422 shares of Synova
common stock in conjunction with the January 12, 2007 merger of Allendale with and into a wholly owned subsidiary of Synova, and further acknowledge that nothing in this Agreement shall have any affect on Radiant’s said current stock
ownership. 
 2. Allendale shall pay Radiant the sum of $100,000.00 (“Settlement Payment Amount”). Said Settlement Payment Amount
in the form of a check made payable to “Radiant Technologies, Inc.” shall be forwarded to Radiant upon the execution of this Agreement. 
 3. Radiant shall transfer, assign and/or convey to Synova, together with all rights to Today® Product returns authorized by Radiant or Allendale or both, all accounts receivable with retailers associated with the sale of said Products outstanding as of April 25, 2007, which
accounts receivable totaled approximately $779,000 pursuant to Radiant’s books. Radiant shall provide Synova with written proof and 

  

 Page 3 

 
confirmation of the transfer, assignment and/or conveyance of said outstanding accounts receivable, in whatever form is acceptable to the respective
retailers, within ten (10) days of the execution of this Agreement, or as soon thereafter as is reasonable based upon delays caused by the retailer accounts. Further, within three (3) days of collecting any monies involving the outstanding
accounts receivable described in this Paragraph 3, Radiant shall promptly transfer said monies to Synova. 
 4. Allendale agrees to indemnify
and hold harmless Radiant for any claims brought by retail customers for product liability, product defects, recalls, retailer credits, or allowances for returns or in store promotions, or any other claims or charges asserted by retail customers in
connection with those accounts being transferred, assigned and/or conveyed to Allendale by Radiant pursuant to this Agreement, but only to the extent such claims are not covered by the Parties’ insurance policies. Further, it is agreed that
Allendale has no obligation to indemnify and hold harmless Radiant as to any claims that result or arise from Radiant’s own negligence or reckless or willful misconduct, nor from any such claims that Radiant has or should have knowledge of at
the time this Agreement is executed. Radiant acknowledges that it is not aware of any such claims having been asserted, or made or otherwise existing as of the date this Agreement is being executed. Allendale shall name Radiant as an additional
named insured on its products liability policy covering the sale of Allendale products. Allendale acknowledges that, in reliance on this representation by Allendale, Radiant is discontinuing all products liability insurance coverage pertaining to
the sale of Allendale products. 
  

 Page 4 

	B.	Parties’ Mutual Release of Claims 

 In
consideration of the above, the Parties hereby FULLY, COMPLETELY AND FOREVER RELEASE AND DISCHARGE each other and each of their past, present and future parents, affiliates, subsidiaries, divisions, partners, shareholders, officers, directors,
employees, representatives, agents, servants, attorneys, and the predecessors, heirs, executors, administrators, trustees, successors and assigns of each of them, of and from any and all past, present and future claims, actions, causes of action,
suits, debts, dues, sums of money, attorneys’ fees, accounts, reckonings, bonds, bills, specialties, covenants, contracts, appraisal rights, controversies, judgments, extends, executions, liabilities, demands or obligations of any kind
whatsoever, whether in law or equity, which they ever had, now have or hereafter can, shall or may have against each other and each of their past, present and future parents, affiliates, subsidiaries, divisions, partners, shareholders, officers,
directors, employees, representatives, agents, servants, attorneys, and the predecessors, heirs, executors, administrators, trustees, successors and assigns of each of them, for, upon or by reason of any matter, cause or thing whatsoever, whether
now known or unknown, fixed or unliquidated, conditional or contingent, which currently exists or subsequently accrues with respect to any and all claims including, but not limited to, those claims relating to or arising out of the Distribution
Agreement, the Loan and Credit Agreement and the Stock Purchase Agreement as well as all other claims that were brought or could have been brought in the Lawsuit. 
  

	C.	Dismissal With Prejudice 

 For and in
consideration of the promises and consideration described in this Agreement, and as a material inducement to the Parties to enter into this Agreement, the Parties willingly and knowingly agree to execute and file with the Court a Stipulation of
Dismissal with Prejudice as to any and all claims raised in the Lawsuit. 
  

 Page 5 

	D.	No Admission of Liability 

 1. The purpose of
this Agreement is to resolve fully, completely and finally all past, present and future matters, controversies, claims, and disputes between and among the Parties. 
 2. This Agreement is the result of a compromised settlement of disputed claims and defenses and is not and shall not be construed as an admission or concession of responsibility, liability or any wrongdoing on the
part of any Party. To the contrary, the Parties expressly deny any and all allegations and claims asserted against each other in the Lawsuit. 
 3. The Parties specifically disclaim violating any law or committing any unlawful action against each other, and expressly deny any liability, responsibility or obligation to each other with regard to the allegations and claims raised and
asserted in the Lawsuit. 
  

	E.	Confidentiality 

 1. The terms of this
Agreement, the fact that this Agreement has been entered into, and all negotiations leading up to the execution of the Agreement, shall be deemed CONFIDENTIAL and shall not be further disclosed to any person or entity except as required by
applicable law, rule or regulation (including, without limitation, the requirements under any federal or state securities laws, rules or regulations (or any judicial or regulatory interpretations thereof) applicable to Synova that may require
disclosure of the terms of this Agreement or the fact that this Agreement has been entered into), or with the written consent of the Parties hereto following the execution of 

  

 Page 6 

 
this Agreement; provided, however, that nothing in this Agreement shall prevent any Party hereto from disclosing the existence or terms of this Agreement in
the course of the Parties’ normal business affairs, as regarding communications with their accountants, advisors, insurance companies, attorneys, and all regulatory agencies/bodies having a bona fide need to know such information, or in
any judicial proceeding to enforce or construe this Agreement. 
 2. From and after the date of this Agreement, neither Party shall make any
public disparaging statements concerning the officers, directors, employees, attorneys, agents, or of the business or operations, of the other Party. This non-disparagement provision shall not in any way prevent the parties from disclosing any
information to their attorneys, in response to a lawful subpoena or court order requiring disclosure of information, or in connection with any litigation involving either Party. 
  

	F.	Assignment 

 The Parties hereto represent and
warrant that they have not assigned nor otherwise transferred or assigned any claims or rights they may have arising out of or relating in any way to the claims in the Lawsuit, the Distribution Agreement, the Loan and Credit Agreement, and/or the
Stock Purchase Agreement. 
  

	G.	Further Assurances 

 Radiant agrees that it
will (1) promptly execute and deliver to Synova all further documents, agreements and instruments, (2) deliver in writing customary representations and warranties, and (3) provide Synova with such other documents or information,
reasonably requested by Synova or Allendale (whether in connection with or following the execution of this Agreement). 
  

 Page 7 

	H.	Representations and Warranties 

 1. The
Parties hereto represent and warrant to each other that the execution and delivery of this Agreement have been done freely and voluntarily and, to the extent necessary, have been duly and validly authorized and approved as need be, and that no
further action is necessary to make this Agreement valid and binding on each of the Parties hereto. 
 2. The Parties hereto further
represent and warrant to each other that: 
 a. Each Party has participated in the drafting of this Agreement after consulting with counsel;

 b. This Agreement was reviewed and approved by counsel for all Parties and that no Party shall maintain that the language of the Agreement
should be construed against any other Party by virtue of that Party’s putative role as drafter; 
 c. No representations, warranties or
promises have been made or relied upon by any of the Parties other than as expressly set forth herein; 
 d. They have read this Agreement;

 e. They have not been coerced into signing this Agreement; 
 f. They have the full and express authority to execute it on behalf of each Party on whose behalf they have signed; and 
 g. They understand its contents and are executing it freely and voluntarily with an intent to bind their respective Parties to its terms. 
  

	I.	Entire Agreement 

 1. This Agreement
constitutes the entire agreement of the Parties with respect to the subject matter hereof and supersedes all prior written or oral agreements, understandings, and negotiations. 
  

 Page 8 

 2. This Agreement may be modified only by a written amendment signed by the Parties, and no waiver of any
provision of this Agreement or the breach thereof shall be effective unless expressed in a writing signed by the waiving Party. The waiver by any Party hereto of any of the provisions of this Agreement or the breach thereof shall not operate or be
construed as a waiver of any subsequent or other breach. 
  

	J.	Governing Law 

 This Agreement shall be
interpreted, enforced, and governed under the laws of New Jersey. 
  

	K.	Severability 

 If any provision of this
Agreement is declared or determined by any court to be illegal or invalid, that part shall be excluded from the Agreement, but the validity of the remaining parts, terms, or provisions shall not be affected. 
  

	L.	Headings 

 Headings contained herein are for
purposes of organization only, and shall not constitute a part of this Agreement. 
 [signatures appear on following page] 

 

 Page 9 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed on their behalf by the
signatures of their duly authorized representatives below. 
  

									
	 ALLENDALE PHAMACUETICALS, INC.
	 		 	RADIANT TECHNOLOGIES, INC.
					
	 BY:
	 	 /s/ Robert L. Edwards
	 		 	BY:	 	 /s/ Mitch Gray

	 Dated:
	 	May 31, 2007	 		 	Dated:	 	May 31, 2007
			
	 TODAY’S WOMENCARE COMPANY
	 		 	PATHFINDER MANAGEMENT, INC.
					
	 BY:
	 	 /s/ Robert L. Edwards
	 		 	BY:	 	 /s/ Mitch Gray

	 Dated:
	 	May 31, 2007	 		 	Dated:	 	May 31, 2007
			
	 SYNOVA HEALTHCARE GROUP, INC.
	 		 	
					
	 BY:
	 	 /s/ Robert L. Edwards
	 		 		 	
	 Dated:
	 	May 31, 2007	 		 		 	

  

 Page 10Form of Restricted Stock Award Agreement

 Exhibit 10.3 
 SYNOVA HEALTHCARE GROUP, INC. 
 2005 EQUITY INCENTIVE PLAN 
 RESTRICTED STOCK AWARD AGREEMENT 
 This Restricted Stock Award Agreement (“Agreement”), dated as of April 3, 2007 (the “Award Date”), is being entered into by and between Synova Healthcare Group, Inc., a Nevada corporation (the “Company”),
and
                                        
(“Participant”). 
 Background 
 The Company has adopted the Synova Healthcare Group, Inc. 2005 Equity Incentive Plan (the “Plan”) providing for the grant, from time to time, of, among other things, awards of restricted stock to its
employees, officers and directors, as well as to non-employees and consultants who are in a position to make a significant contribution to the Company’s success. The Board of Directors of the Company (the “Board”) has determined to
grant an Award of Restricted Stock under the Plan to Participant, subject to and on the terms and conditions set forth in this Agreement. 
 Agreement 
 NOW, THEREFORE, intending to be legally bound, and incorporating the foregoing Background premises, the parties
agree as follows: 
 1. Restricted Stock Award. The Company hereby grants to Participant an Award of Restricted Stock in the amount of
34,574 shares of Common Stock (the “Shares”) pursuant to the Plan, as the same may from time to time be amended, and upon the terms and conditions and subject to the restrictions therein and hereinafter set forth. By executing this
Agreement, Participant hereby accepts the Award of Restricted Stock and the terms and conditions of the Agreement. 
 2. Terms and
Conditions. 
 (a) Vesting. Except as otherwise provided in the Plan and this Agreement, and contingent upon
Participant’s continued membership on the Board as of and through the date of the Company’s 2007 Annual Meeting of Stockholders, one hundred percent (100%) of the Shares shall vest and become non-forfeitable on the first anniversary
of the Award Date (such anniversary, the “Vesting Date”). 
 (b) Certificates. Certificates evidencing the
Shares shall be issued by the Company and shall be registered in Participant’s name on the stock transfer books of the Company promptly after the date hereof, but shall remain in the physical custody of the Company or its designee at all times
prior to, in the case of any particular Shares, the applicable Vesting Date. As a condition to the receipt of this Restricted Stock Award, Participant shall deliver to the Company a stock power, duly endorsed in blank, relating to the Shares.

 (c) Effect of Status Change. The provisions of Section 6 of the Plan related
to a Status Change of Participant shall apply to this Award. Notwithstanding the foregoing and Section 5.2(c)(3) of the Plan, no payment shall be made to Participant for any forfeited Shares. 
 (d) Rights as a Stockholder; Dividends. Notwithstanding Sections 7.2 and 11 of the Plan, once (i) Participant makes any
required payments in respect of the Shares, (ii) Participant furnishes the Company with any required agreements, and (iii) Participant actually receives the Shares or the Company has physical custody of the certificate(s) evidencing the
Shares registered in Participant’s name on the stock transfer books of the Company, Participant shall be the full record and beneficial owner of the Shares. Unless and until such Shares are forfeited or sold or otherwise disposed of, and as
record owner, Participant shall be entitled to all rights of a common stockholder of the Company, including, without limitation, voting rights, if any, with respect to the Shares; provided that any cash or in-kind dividends paid with respect
to unvested Shares shall be withheld by the Company and shall be paid to Participant, without interest, only when, and if, such Shares shall become vested. As soon as practicable following the vesting of any Shares, but in no event later than
March 15 of the calendar year following the calendar year in which the Shares vest, certificates for such vested Shares and any cash dividends or in-kind dividends credited to Participant’s account with respect to such Shares shall be
delivered to Participant or Participant’s beneficiary along with the stock power relating thereto. 
 (e) Restrictive
Legends. All certificates representing the Shares shall have affixed thereto legends in substantially the following form, in addition to any other legends that may be required under federal or state securities laws: 
 A TRANSFER OF THIS CERTIFICATE AND THE SHARES REPRESENTED HEREBY IS RESTRICTED PURSUANT TO THE TERMS OF THE SYNOVA HEALTHCARE GROUP, INC. 2005 EQUITY
INCENTIVE PLAN AND A RESTRICTED STOCK AWARD AGREEMENT, DATED AS OF APRIL 3, 2007, BETWEEN SYNOVA HEALTHCARE GROUP, INC. AND THE HOLDER OF THIS CERTIFICATE. A COPY OF SUCH PLAN AND AGREEMENT IS ON FILE AT THE OFFICES OF SYNOVA HEALTHCARE GROUP, INC.

 In addition, the following legend (the “Securities Legend”) shall also be affixed to any certificate representing
the Shares: 
 THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER
APPLICABLE STATE SECURITIES LAWS. THE SHARES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND
UNDER ANY APPLICABLE STATE SECURITIES LAWS, AND, IN ANY EVENT, WITHOUT AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY (BOTH AS TO SUCH COUNSEL AND THE FORM AND SUBSTANCE OF SUCH OPINION) THAT THE PROPOSED TRANSACTION WILL BE EXEMPT FROM SUCH
REGISTRATION. 
  

 -2- 

 3. Representations and Warranties of Participant. Participant acknowledges and understands that
the Shares have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or under applicable state securities laws. Participant hereby agrees, represents and warrants that Participant is acquiring the Shares
for Participant’s own account for investment purposes only, and not with a view to, or in connection with, any resale or other distribution of any of such shares, except as otherwise specifically permitted by the Plan or this Agreement.
Participant further agrees that the Shares or any interest therein may not be sold, assigned, exchanged, pledged, encumbered, gifted or otherwise disposed of or transferred by Participant, until the conditions set forth in Section 4 of this
Agreement have been satisfied and except as otherwise may be permitted by applicable law, including all applicable federal, state or other securities laws. Participant shall execute and deliver such further instruments, representations,
acknowledgments and agreements as the Company may, in its sole discretion, deem advisable to avoid any violation of federal, state, local or other rule, regulation or law. Subject to the restrictions set forth in the Plan, the Committee may
accelerate the time at which the restrictions on all or any part of the Shares shall lapse. 
 4. Delivery of the Shares; Removal of
Restrictions. The Company shall not be obligated to deliver the Shares or remove the Securities Legend from the Shares: (i) until all conditions to the Award have been satisfied or removed, (ii) until, in the opinion of counsel to the
Company, all applicable federal and state laws and regulations have been complied with, (iii) if the outstanding Common Stock is at the time listed on any stock exchange or included for quotation on an inter-dealer quotation system, until the
Shares to be delivered have been listed or included or authorized to be listed or included on such exchange or system upon official notice of issuance, (iv) if it might cause the Company to issue or sell more shares of Common Stock than the
Company is then legally entitled to issue or sell, and (v) until all other legal matters in connection with the issuance and delivery of such shares have been approved by counsel to the Company. 
 5. Adjustments for Changes in Capitalization of the Company. In the event of any stock dividend, stock split, combination, exchange of equity
securities, merger, consolidation, recapitalization, reorganization, divestiture or other distribution (other than ordinary cash dividends) of assets to stockholders, or any other event affecting the Common Stock that the Board deems, in its sole
discretion, to be similar circumstances, the Board may make such adjustments as it may deem appropriate, in its discretion, to the Award. 
 6. Plan and Plan Interpretations as Controlling. The Shares hereby awarded and the terms and conditions herein set forth are subject in all respects to the terms and conditions of the Plan, which are controlling. All determinations
and interpretations by the Committee or the Board shall be binding and conclusive upon Participant or Participant’s legal representatives with regard to any question arising hereunder or under the Plan. The provisions of the Plan are hereby
incorporated in this Agreement by reference. By signing this Agreement, Participant acknowledges that he or she has received a copy of the Plan and has had an opportunity to review the Plan and agrees to be bound by all of the terms and provisions
of the Plan. 
  

 -3- 

 7. Participant Service. Nothing in this Agreement shall confer upon Participant the right or
obligation to continue to serve as a member of the Board and this Agreement shall not affect Participant’s ability to resign, retire or otherwise be removed from office. 
 8. Withholding and Social Security Taxes. Upon the vesting of the Shares (or any such earlier time, if any, that an election is made under
Section 83(b) of the Internal Revenue Code of 1986, as amended (the “Code”), or any successor provision thereto, to include the value of such Shares in taxable income), the Company shall have the right to withhold from
Participant’s compensation an amount sufficient to fulfill its or any affiliated person’s obligations for any applicable withholding and employment taxes. Alternatively, the Company may require Participant to pay the Company the amount of
any taxes that the Company is required to withhold with respect to the Shares, or, in lieu thereof, to retain or sell without notice a sufficient number of Shares to cover the amount required to be withheld. The Company shall withhold from any cash
dividends paid on the Restricted Stock an amount sufficient to cover taxes owed as a result of the dividend payment. The Company’s method of satisfying its withholding obligations shall be solely in the discretion of the Company, subject to
applicable federal, state and local laws. 
 9. Tax Consequences. Participant has reviewed with Participant’s own tax advisors
the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. Participant is relying solely on such advisors and not on any statements or representations of Company or any of its
agents. Participant understands that Participant (and not Company) shall be responsible for Participant’s own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement. Participant
understands that Section 83 of the Code taxes (as ordinary income) the fair market value of the Shares as of the date any “restrictions” on the Shares lapse. To the extent that a grant hereunder is not otherwise an exempt transaction
for purposes of Section 16(b) of the Securities and Exchange Act of 1934 (the “Exchange Act”), with respect to officers, directors and 10% shareholders, a “restriction” on the Shares includes for these purposes the period
after the grant of the Shares during which such officers, directors and 10% shareholders could be subject to suit under Section 16(b) of the Exchange Act. Alternatively, Participant understands that Participant may elect to be taxed at the time
the Shares are granted rather than when the restrictions on the Shares lapse, or the Section 16(b) period expires, by filing an election under Section 83(b) of the Code with the Internal Revenue Service within 30 days from the Award Date.
If Participant makes an election with respect to the Shares under Section 83(b) of the Code, Participant shall deliver to the Company a copy of such election within ten days of the filing of such election with the Internal Revenue Service.

 PARTICIPANT ACKNOWLEDGES THAT IT IS PARTICIPANT’S SOLE RESPONSIBILITY AND NOT THE COMPANY’S TO FILE TIMELY THE ELECTION AVAILABLE TO
PARTICIPANT UNDER SECTION 83(B) OF THE CODE, EVEN IF PARTICIPANT REQUESTS THAT THE COMPANY OR ITS REPRESENTATIVES MAKE THIS FILING ON PARTICIPANT’S BEHALF. 
 10. Amendment; Choice of Law; Consent to Jurisdiction. This Agreement and the Plan constitute the entire understanding and agreement between the Company and Participant with respect to the subject matter
hereof, and supersede all other negotiations, understandings, 

  

 -4- 

 
discussions, representations (if any) and agreements made by and between such parties with respect to the subject matter hereof. No amendment, supplement or
waiver of this Agreement, in whole or in part, shall be binding upon the Company unless in writing and signed by the Chairman and Chief Executive Officer of the Company. This Agreement and the performance of the parties hereunder shall be construed
in accordance with and governed by the laws of the Commonwealth of Pennsylvania, except that matters of corporate law, power and authority covered by Chapters 78 and 92A, Nevada Revised Statutes, as they may be amended from time to time, or any of
their successor provisions, shall be construed in accordance with such provisions. Any action to enforce this Agreement must be brought in, and the parties hereby consent to the jurisdiction of, courts situated in Delaware County, Pennsylvania or
the U.S. federal courts located in the Eastern District of Pennsylvania, Philadelphia Division. Each party hereby waives the right to claim that any such court is an inconvenient forum for the resolution of any such action. 
 11. JURY TRIAL WAIVER. THE PARTIES EXPRESSLY AND KNOWINGLY WAIVE ANY RIGHT TO A JURY TRIAL IN THE EVENT ANY ACTION ARISING UNDER OR IN CONNECTION
WITH THIS AGREEMENT IS LITIGATED OR HEARD IN ANY COURT. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 -5- 

 IN WITNESS WHEREOF, this Agreement has been executed as of the date and year first above written.

  

			
	SYNOVA HEALTHCARE GROUP, INC.
		
	 By:
	 	  

		 	Stephen E. King
		 	Chairman and Chief Executive Officer
	
	PARTICIPANT:
	
	

	 Name:
	 	

  

 -6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]